查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1421811

腫瘤伴隨診斷市場、份額、規模、趨勢、行業分析報告：按產品、按技術、按疾病類型、按最終用戶、按地區、按細分市場、預測，2023-2032 年

Oncology Companion Diagnostic Market Share, Size, Trends, Industry Analysis Report, By Offering (Product, Services); By Technology; By Disease Type; By End User; By Region; Segment Forecast, 2023- 2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，到 2032 年，全球腫瘤伴隨診斷市場預計將達到 105.7 億美元。 該報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

向以患者為中心的醫療保健的轉變正在為伴隨診斷創造有利的環境。 這些工具使醫療保健提供者能夠制定量身定制的治療計劃，最大限度地減少副作用並優化患者的治療結果。 這種以病人為中心的方法在醫療保健環境中越來越受到重視。 患者對伴隨診斷的認識不斷提高，為擴大採用伴隨診斷提供了機會。 讓患者參與治療並向他們提供有關這些診斷的好處的資訊將推動市場成長。

伴隨診斷提供了一條實現更具成本效益的醫療保健途徑。 透過減少無效治療的使用並最大限度地減少住院和併發症，這些工具有助於控制醫療費用。 市場受益於旨在發現與各種癌症類型相關的新生物標記和遺傳標記的持續研究工作。 這些發現擴大了伴隨診斷的應用，並為市場成長提供了新的機會。

新興國家擁有龐大的成長機會。 由於醫療基礎設施的改善和意識的提高，預計這些地區伴隨診斷的採用將顯著增加。 遠距醫療和遠距診斷在醫療保健領域的擴展提供了改善伴隨診斷測試的機會。 這一趨勢擴大了市場基礎，特別是在服務不足和偏遠地區。

診斷技術的創新，包括液體活檢和新一代定序，為更準確、更全面的伴隨診斷提供了機會。 這些創新將提高診斷準確性並擴大測試能力。

腫瘤伴隨診斷市場報告亮點

由於癌症發生率上升、世界人口老化以及精準醫療的進步，該產品領域將在2022年佔據較大份額

免疫組織化學因其廣泛用於生物標記檢測、亞型分型和治療指導而成為最大的細分領域。

預計乳癌領域將在預測期內出現顯著增長，這主要是由於標靶治療和監管支持的採用增加。

到 2022 年，醫院細分市場將佔據最大的市場收入份額，主要得益於早期檢測和診斷、治療監測以及以患者為中心的護理

由於個人化醫療、監管框架、合作夥伴關係和協作研究的興起，北美地區在 2022 年佔據了大部分市場份額。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第 4 章全球腫瘤伴隨診斷市場洞察

  • 腫瘤學伴隨診斷 - 產業概況
  • 腫瘤伴隨診斷市場動態
    • 推動者和機會
      • 癌症病例不斷增加、癌症標靶治療的可用性不斷擴大以及精準醫療取得進展
      • 日益關注個人化醫療
    • 抑制因素和挑戰
      • 監理問題與審批流程
  • 杵分析
  • 腫瘤伴隨診斷產業的趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章全球腫瘤伴隨診斷市場（依技術）

  • 主要發現
  • 簡介
  • 免疫組織化學
  • 次世代定序
  • 聚合□鍊式反應
  • 其他

第 6 章全球腫瘤伴隨診斷市場（以報價）

  • 主要發現
  • 簡介
  • 產品
  • 服務

第 7 章依疾病類型劃分的全球腫瘤伴隨診斷市場

  • 主要發現
  • 簡介
  • 黑色素瘤
  • 乳癌
  • 大腸直腸癌
  • 白血病
  • 攝護腺癌
  • 其他

第 8 章全球腫瘤伴隨診斷市場（按最終用戶）

  • 主要發現
  • 簡介
  • 醫院
  • 診斷實驗室
  • 其他

第 9 章按地區劃分的全球腫瘤伴隨診斷市場

  • 主要發現
  • 簡介
    • 2019-2032 年腫瘤伴隨診斷市場評估，地區
  • 腫瘤伴隨診斷市場 - 北美
    • 北美：腫瘤伴隨診斷市場（按技術），2019-2032 年
    • 北美：腫瘤伴隨診斷市場，按最終用戶劃分，2019-2032 年
    • 北美：2019-2032 年腫瘤伴隨診斷市場（依產品劃分）
    • 北美：腫瘤伴隨診斷市場（依疾病類型），2019-2032 年
    • 腫瘤伴隨診斷市場 - 美國
    • 腫瘤伴隨診斷市場 - 加拿大
  • 腫瘤伴隨診斷市場 - 歐洲
    • 歐洲：腫瘤伴隨診斷市場（按技術），2019-2032 年
    • 歐洲：腫瘤伴隨診斷市場，依最終使用者劃分，2019-2032 年
    • 歐洲：2019-2032 年腫瘤伴隨診斷市場（依產品劃分）
    • 歐洲：腫瘤伴隨診斷市場（依疾病類型），2019-2032 年
    • 腫瘤伴隨診斷市場 - 英國
    • 腫瘤伴隨診斷市場 - 法國
    • 腫瘤伴隨診斷市場 - 德國
    • 腫瘤伴隨診斷市場 - 義大利
    • 腫瘤伴隨診斷市場 - 西班牙
    • 腫瘤伴隨診斷市場 - 荷蘭
    • 腫瘤伴隨診斷市場 - 俄羅斯
  • 腫瘤伴隨診斷市場 - 亞太地區
    • 亞太地區：腫瘤伴隨診斷市場（按技術），2019-2032 年
    • 亞太地區：腫瘤伴隨診斷市場，依最終用戶劃分，2019-2032 年
    • 亞太地區：腫瘤伴隨診斷市場（按產品劃分），2019-2032 年
    • 亞太地區：2019-2032 年腫瘤伴隨診斷市場（依疾病類型）
    • 腫瘤伴隨診斷市場 - 中國
    • 腫瘤伴隨診斷市場 - 印度
    • 腫瘤伴隨診斷市場 - 日本
    • 腫瘤伴隨診斷市場 - 馬來西亞
    • 腫瘤伴隨診斷市場 - 印度尼西亞
    • 腫瘤伴隨診斷市場 - 韓國
  • 腫瘤伴隨診斷市場 - 中東和非洲
    • 中東和非洲：腫瘤伴隨診斷市場（按技術），2019-2032 年
    • 中東和非洲：腫瘤伴隨診斷市場，按最終用戶劃分，2019-2032 年
    • 中東與非洲：2019-2032 年腫瘤伴隨診斷市場（依產品劃分）
    • 中東和非洲：腫瘤伴隨診斷市場（按疾病類型），2019-2032 年
    • 腫瘤伴隨診斷市場 - 沙烏地阿拉伯
    • 腫瘤伴隨診斷市場 - 南非
    • 腫瘤伴隨診斷市場 - 以色列
    • 腫瘤伴隨診斷市場 - 阿聯酋
  • 腫瘤伴隨診斷市場 - 拉丁美洲
    • 拉丁美洲：腫瘤伴隨診斷市場（按技術），2019-2032 年
    • 拉丁美洲：腫瘤伴隨診斷市場，按最終用戶劃分，2019-2032 年
    • 拉丁美洲：腫瘤伴隨診斷市場，依報價，2019-2032 年
    • 拉丁美洲：2019-2032 年腫瘤伴隨診斷市場（依疾病類型）
    • 腫瘤伴隨診斷市場 - 墨西哥
    • 腫瘤伴隨診斷市場 - 巴西
    • 腫瘤伴隨診斷市場 - 阿根廷

第10章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第十一章公司簡介

  • Abbott Laboratories
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Biocartis
  • Exact Sciences
  • Genedrive
  • Genomic Health
  • Guardant Health
  • Illumina
  • Invivoscribe
  • Myriad Genetics
  • QIAGEN
  • Roche Diagnostics
  • Sysmex Corporation
  • Thermo Fisher Scientific
Product Code: PM4133

The global oncology companion diagnostic market size is expected to reach USD 10.57 billion by 2032, according to a new study by Polaris Market Research. The report "Oncology Companion Diagnostic Market Share, Size, Trends, Industry Analysis Report, By Offering (Product, Services); By Technology; By Disease Type; By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The shift towards patient-centered healthcare has created a favorable environment for companion diagnostics. These tools enable healthcare providers to design tailored treatment plans, minimizing side effects and optimizing patient outcomes. This patient-centric approach is increasingly valued in the healthcare landscape. The rising awareness of companion diagnostics among patients provides an opportunity for increased adoption. Engaging patients in their care and empowering them with information about the benefits of these diagnostics drives market growth.

Companion diagnostics offer a route to more cost-effective healthcare. By reducing the use of ineffective therapies and minimizing the occurrence of hospitalizations and complications, these tools contribute to healthcare cost containment. The market benefits from ongoing research efforts aimed at discovering new biomarkers and genetic markers associated with various cancer types. These discoveries expand the applications of companion diagnostics, opening up new opportunities for market growth.

Emerging economies offer a significant growth opportunity. As these regions improve healthcare infrastructure and increase awareness, the adoption of companion diagnostics is poised for substantial growth. The expansion of telemedicine and remote diagnostics in healthcare presents opportunities to increase access to companion diagnostic testing. This trend, particularly relevant in underserved or remote areas, broadens the market's reach.

The ongoing innovations in diagnostic technologies, including liquid biopsies and next-generation sequencing, present opportunities for more accurate and comprehensive companion diagnostics. These innovations can lead to greater diagnostic precision and expanded testing capabilities.

Oncology Companion Diagnostic Market Report Highlights

Product segment held a significant share in 2022, owing to growing cancer prevalence, global aging population, and advancements in precision medicine

Immunohistochemistry emerged as the largest segment on account of its wide use in biomarker detection, subtype classification, and treatment guidance

The breast cancer segment is expected to experience significant growth during the forecast period, which is mainly driven by its growing adoption of targeted therapies and regulatory support

Hospitals segment held the maximum market revenue share in 2022, mainly for early detection and diagnosis, treatment monitoring, and patient-centric care

North America region dominated the market with majority share in 2022, owing to the rise of personalized medicine, regulatory framework, and partnerships and collaborations

The global key market players include: Abbott Laboratories, Agilent Technologies, Illumina, Invivoscribe, Roche Diagnostics, Sysmex Corporation, and Thermo Fisher Scientific, among others

Polaris Market Research has segmented the Oncology Companion Diagnostic market report based on offering, technology, disease type, end user, and region:

Oncology Companion Diagnostic, Offering Outlook (Revenue - USD Billion, 2019 - 2032)

  • Product
  • Services

Oncology Companion Diagnostic, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • Immunohistochemistry
  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Others

Oncology Companion Diagnostic, Disease Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Melanoma
  • Breast Cancer
  • Colorectal Cancer
  • Leukaemia
  • Prostate Cancer
  • Others

Oncology Companion Diagnostic, End User Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Diagnostic Labs
  • Others

Oncology Companion Diagnostic, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Oncology Companion Diagnostic Market Insights

  • 4.1. Oncology Companion Diagnostic - Industry Snapshot
  • 4.2. Oncology Companion Diagnostic Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising cancer cases, growing availability of targeted cancer therapies, and precision medicine advancements
      • 4.2.1.2. Growing emphasis on personalized medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory challenges and approval processes
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Oncology Companion Diagnostic Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Oncology Companion Diagnostic Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • 5.3. Immunohistochemistry
    • 5.3.1. Global Oncology Companion Diagnostic Market, by Immunohistochemistry, by Region, 2019-2032 (USD Billion)
  • 5.4. Next-Generation Sequencing
    • 5.4.1. Global Oncology Companion Diagnostic Market, by Next-Generation Sequencing, by Region, 2019-2032 (USD Billion)
  • 5.5. Polymerase Chain Reaction
    • 5.5.1. Global Oncology Companion Diagnostic Market, by Polymerase Chain Reaction, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Oncology Companion Diagnostic Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Oncology Companion Diagnostic Market, by Offering

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • 6.3. Product
    • 6.3.1. Global Oncology Companion Diagnostic Market, by Product, by Region, 2019-2032 (USD Billion)
  • 6.4. Services
    • 6.4.1. Global Oncology Companion Diagnostic Market, by Services, by Region, 2019-2032 (USD Billion)

7. Global Oncology Companion Diagnostic Market, by Disease Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Oncology Companion Diagnostic Market, by Disease Type, 2019-2032 (USD Billion)
  • 7.3. Melanoma
    • 7.3.1. Global Oncology Companion Diagnostic Market, by Melanoma, by Region, 2019-2032 (USD Billion)
  • 7.4. Breast Cancer
    • 7.4.1. Global Oncology Companion Diagnostic Market, by Breast Cancer, by Region, 2019-2032 (USD Billion)
  • 7.5. Colorectal Cancer
    • 7.5.1. Global Oncology Companion Diagnostic Market, by Colorectal Cancer, by Region, 2019-2032 (USD Billion)
  • 7.6. Leukaemia
    • 7.6.1. Global Oncology Companion Diagnostic Market, by Leukaemia, by Region, 2019-2032 (USD Billion)
  • 7.7. Prostate Cancer
    • 7.7.1. Global Oncology Companion Diagnostic Market, by Prostate Cancer, by Region, 2019-2032 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Oncology Companion Diagnostic Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Oncology Companion Diagnostic Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Oncology Companion Diagnostic Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 8.4. Diagnostic Labs
    • 8.4.1. Global Oncology Companion Diagnostic Market, by Diagnostic Labs, by Region, 2019-2032 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Oncology Companion Diagnostic Market, by Others, by Region, 2019-2032 (USD Billion)

9. Global Oncology Companion Diagnostic Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Oncology Companion Diagnostic Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Oncology Companion Diagnostic Market - North America
    • 9.3.1. North America: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
    • 9.3.2. North America: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
    • 9.3.3. North America: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
    • 9.3.4. North America: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.3.5. Oncology Companion Diagnostic Market - U.S.
      • 9.3.5.1. U.S.: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.3.6. Oncology Companion Diagnostic Market - Canada
      • 9.3.6.1. Canada: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • 9.4. Oncology Companion Diagnostic Market - Europe
    • 9.4.1. Europe: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.4.5. Oncology Companion Diagnostic Market - UK
      • 9.4.5.1. UK: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.4.6. Oncology Companion Diagnostic Market - France
      • 9.4.6.1. France: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.4.7. Oncology Companion Diagnostic Market - Germany
      • 9.4.7.1. Germany: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.4.8. Oncology Companion Diagnostic Market - Italy
      • 9.4.8.1. Italy: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.4.9. Oncology Companion Diagnostic Market - Spain
      • 9.4.9.1. Spain: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.4.10. Oncology Companion Diagnostic Market - Netherlands
      • 9.4.10.1. Netherlands: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.4.11. Oncology Companion Diagnostic Market - Russia
      • 9.4.11.1. Russia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • 9.5. Oncology Companion Diagnostic Market - Asia Pacific
    • 9.5.1. Asia Pacific: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.5.5. Oncology Companion Diagnostic Market - China
      • 9.5.5.1. China: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.5.6. Oncology Companion Diagnostic Market - India
      • 9.5.6.1. India: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.5.7. Oncology Companion Diagnostic Market - Japan
      • 9.5.7.1. Japan: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.5.8. Oncology Companion Diagnostic Market - Malaysia
      • 9.5.8.1. Malaysia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.5.9. Oncology Companion Diagnostic Market - Indonesia
      • 9.5.9.1. Indonesia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.5.10. Oncology Companion Diagnostic Market - South Korea
      • 9.5.10.1. South Korea: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • 9.6. Oncology Companion Diagnostic Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.6.5. Oncology Companion Diagnostic Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.6.6. Oncology Companion Diagnostic Market - South Africa
      • 9.6.6.1. South Africa: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.6.7. Oncology Companion Diagnostic Market - Israel
      • 9.6.7.1. Israel: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.6.8. Oncology Companion Diagnostic Market - UAE
      • 9.6.8.1. UAE: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • 9.7. Oncology Companion Diagnostic Market - Latin America
    • 9.7.1. Latin America: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.7.5. Oncology Companion Diagnostic Market - Mexico
      • 9.7.5.1. Mexico: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.7.6. Oncology Companion Diagnostic Market - Brazil
      • 9.7.6.1. Brazil: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
    • 9.7.7. Oncology Companion Diagnostic Market - Argentina
      • 9.7.7.1. Argentina: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Agilent Technologies
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Bio-Rad Laboratories
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Biocartis
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Exact Sciences
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Genedrive
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Genomic Health
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Guardant Health
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Illumina
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Invivoscribe
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Myriad Genetics
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. QIAGEN
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Roche Diagnostics
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Sysmex Corporation
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Thermo Fisher Scientific
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development

List of Tables

  • Table 1 Global Oncology Companion Diagnostic Market, by Technology, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Oncology Companion Diagnostic Market, by Offering, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Oncology Companion Diagnostic Market, by Disease type, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Oncology Companion Diagnostic Market, by End User, by Region, 2019-2032 (USD Billion)
  • Table 5 Oncology Companion Diagnostic Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 7 North America: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 8 North America: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 9 North America: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 10 U.S.: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 11 U.S.: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 12 U.S.: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 13 U.S.: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 14 Canada: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 15 Canada: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 16 Canada: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 17 Canada: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 18 Europe: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 19 Europe: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 20 Europe: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 21 Europe: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 22 Germany: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 23 Germany: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 24 Germany: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 25 Germany: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 26 France: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 27 France: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 28 France: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 29 France: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 30 UK: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 31 UK: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 32 UK: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 33 UK: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 34 Italy: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 35 Italy: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 36 Italy: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 37 Italy: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 42 Spain: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 43 Spain: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 44 Spain: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 45 Spain: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 46 Russia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 47 Russia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 48 Russia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 49 Russia: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 54 China: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 55 China: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 56 China: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 57 China: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 58 Japan: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 59 Japan: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 60 Japan: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 61 Japan: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 62 India: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 63 India: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 64 India: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 65 India: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 74 South Korea: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 75 South Korea: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 76 South Korea: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 77 South Korea: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 78 Latin America: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 79 Latin America: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 80 Latin America: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 81 Latin America: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 82 Brazil: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 83 Brazil: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 84 Brazil: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 85 Brazil: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 86 Mexico: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 87 Mexico: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 88 Mexico: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 89 Mexico: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 90 Argentina: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 91 Argentina: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 92 Argentina: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 93 Argentina: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 98 UAE: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 99 UAE: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 100 UAE: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 101 UAE: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 106 South Africa: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 107 South Africa: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 108 South Africa: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 109 South Africa: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)
  • Table 110 Israel: Oncology Companion Diagnostic Market, by Technology, 2019-2032 (USD Billion)
  • Table 111 Israel: Oncology Companion Diagnostic Market, by Offering, 2019-2032 (USD Billion)
  • Table 112 Israel: Oncology Companion Diagnostic Market, by Disease type, 2019-2032 (USD Billion)
  • Table 113 Israel: Oncology Companion Diagnostic Market, by End User, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Oncology Companion Diagnostic Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End User
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Technology
  • Figure 7. Global Oncology Companion Diagnostic Market, by Technology, 2021 & 2030 (USD Billion)
  • Figure 8. Market by End User
  • Figure 9. Global Oncology Companion Diagnostic Market, by End User, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Offering
  • Figure 11. Global Oncology Companion Diagnostic Market, by Offering, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Disease type
  • Figure 13. Global Oncology Companion Diagnostic Market, by Disease type, 2021 & 2030 (USD Billion)